Myocardial injury after major non-cardiac surgery evaluated with advanced cardiac imaging: a pilot study.


Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
10 02 2023
Historique:
received: 24 06 2022
accepted: 13 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

Myocardial injury after non-cardiac surgery (MINS) is a frequent complication caused by cardiac and non-cardiac pathophysiological mechanisms, but often it is subclinical. MINS is associated with increased morbidity and mortality, justifying the need to its diagnose and the investigation of their causes for its potential prevention. Prospective, observational, pilot study, aiming to detect MINS, its relationship with silent coronary artery disease and its effect on future adverse outcomes in patients undergoing major non-cardiac surgery and without postoperative signs or symptoms of myocardial ischemia. MINS was defined by a high-sensitive cardiac troponin T (hs-cTnT) concentration > 14 ng/L at 48-72 h after surgery and exceeding by 50% the preoperative value; controls were the operated patients without MINS. Within 1-month after discharge, cardiac computed tomography angiography (CCTA) and magnetic resonance imaging (MRI) studies were performed in MINS and control subjects. Significant coronary artery disease (CAD) was defined by a CAD-RADS category ≥ 3. The primary outcomes were prevalence of CAD among MINS and controls and incidence of major cardiovascular events (MACE) at 1-year after surgery. Secondary outcomes were the incidence of individual MACE components and mortality. We included 52 MINS and 12 controls. The small number of included patients could be attributed to the study design complexity and the dates of later follow-ups (amid COVID-19 waves). Significant CAD by CCTA was equally found in 20 MINS and controls (30% vs 33%, respectively). Ischemic patterns (n = 5) and ischemic segments (n = 2) depicted by cardiac MRI were only observed in patients with MINS. One-year MACE were also only observed in MINS patients (15.4%). This study with advanced imaging methods found a similar CAD frequency in MINS and control patients, but that cardiac ischemic findings by MRI and worse prognosis were only observed in MINS patients. Our results, obtained in a pilot study, suggest the need of further, extended studies that screened systematically MINS and evaluated its relationship with cardiac ischemia and poor outcomes. Trial registration Clinicaltrials.gov identifier: NCT03438448 (19/02/2018).

Sections du résumé

BACKGROUND
Myocardial injury after non-cardiac surgery (MINS) is a frequent complication caused by cardiac and non-cardiac pathophysiological mechanisms, but often it is subclinical. MINS is associated with increased morbidity and mortality, justifying the need to its diagnose and the investigation of their causes for its potential prevention.
METHODS
Prospective, observational, pilot study, aiming to detect MINS, its relationship with silent coronary artery disease and its effect on future adverse outcomes in patients undergoing major non-cardiac surgery and without postoperative signs or symptoms of myocardial ischemia. MINS was defined by a high-sensitive cardiac troponin T (hs-cTnT) concentration > 14 ng/L at 48-72 h after surgery and exceeding by 50% the preoperative value; controls were the operated patients without MINS. Within 1-month after discharge, cardiac computed tomography angiography (CCTA) and magnetic resonance imaging (MRI) studies were performed in MINS and control subjects. Significant coronary artery disease (CAD) was defined by a CAD-RADS category ≥ 3. The primary outcomes were prevalence of CAD among MINS and controls and incidence of major cardiovascular events (MACE) at 1-year after surgery. Secondary outcomes were the incidence of individual MACE components and mortality.
RESULTS
We included 52 MINS and 12 controls. The small number of included patients could be attributed to the study design complexity and the dates of later follow-ups (amid COVID-19 waves). Significant CAD by CCTA was equally found in 20 MINS and controls (30% vs 33%, respectively). Ischemic patterns (n = 5) and ischemic segments (n = 2) depicted by cardiac MRI were only observed in patients with MINS. One-year MACE were also only observed in MINS patients (15.4%).
CONCLUSION
This study with advanced imaging methods found a similar CAD frequency in MINS and control patients, but that cardiac ischemic findings by MRI and worse prognosis were only observed in MINS patients. Our results, obtained in a pilot study, suggest the need of further, extended studies that screened systematically MINS and evaluated its relationship with cardiac ischemia and poor outcomes. Trial registration Clinicaltrials.gov identifier: NCT03438448 (19/02/2018).

Identifiants

pubmed: 36765313
doi: 10.1186/s12872-023-03065-6
pii: 10.1186/s12872-023-03065-6
pmc: PMC9911951
doi:

Banques de données

ClinicalTrials.gov
['NCT03438448']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

78

Subventions

Organisme : Fundació la Marató de TV3
ID : 20150110
Organisme : Instituto de Salud Carlos III
ID : PI16/01162

Informations de copyright

© 2023. The Author(s).

Références

Br J Anaesth. 2018 Apr;120(4):725-733
pubmed: 29576113
J Nucl Cardiol. 2004 Jul-Aug;11(4):450-7
pubmed: 15295414
Clin Biochem. 2015 Mar;48(4-5):201-3
pubmed: 25204966
J Cardiovasc Magn Reson. 2017 Jul 18;19(1):52
pubmed: 28720123
Cardiovasc Pathol. 1999 May-Jun;8(3):133-9
pubmed: 10722235
Circulation. 1999 Sep 7;100(10):1043-9
pubmed: 10477528
Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):202-10
pubmed: 26778592
Lancet. 1999 Apr 24;353(9162):1386-9
pubmed: 10227218
Circ Cardiovasc Imaging. 2015 Mar;8(3):
pubmed: 25711275
BMJ. 2015 Apr 22;350:h1907
pubmed: 25902738
Anesth Analg. 2018 May;126(5):1462-1468
pubmed: 29099425
Rev Esp Cardiol (Engl Ed). 2013 Jun;66(6):504-5
pubmed: 24776058
Clin Res Cardiol. 2021 Sep;110(9):1450-1463
pubmed: 33768367
J Nucl Cardiol. 2020 Aug;27(4):1331-1337
pubmed: 31309459
Neth Heart J. 2013 Aug 20;:
pubmed: 23959850
Atherosclerosis. 2012 May;222(1):191-5
pubmed: 22410124
Radiographics. 2009 Jan-Feb;29(1):89-103
pubmed: 19168838
Eur J Anaesthesiol. 2021 Jun 1;38(6):600-608
pubmed: 33653981
Clin Biochem Rev. 2019 Nov;40(4):201-216
pubmed: 31857741
Int J Cardiol. 1996 Nov 15;57(1):37-44
pubmed: 8960941
J Thromb Haemost. 2015 Jun;13 Suppl 1:S304-12
pubmed: 26149040
Am J Cardiol. 1996 May 15;77(12):1126-8
pubmed: 8644673
J Cardiovasc Comput Tomogr. 2016 Jul-Aug;10(4):269-81
pubmed: 27318587

Auteurs

Jesús Álvarez-Garcia (J)

Department of Cardiology, Hospital Universitario Ramon y Cajal, M-607, 9,100, 28034, Madrid, Spain.
Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, 08026, Barcelona, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Madrid, Spain.

Ekaterine Popova (E)

IIB SANT PAU, Institut d'Investigació Biomèdica Sant Pau, Sant Quintí 77, 08041, Barcelona, Spain. epopova@santpau.cat.
Centro Cochrane Iberoamericano, Sant Antoni Maria Claret, 167, 08025, Barcelona, Spain. epopova@santpau.cat.

Miquel Vives-Borrás (M)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, 08026, Barcelona, Spain.
Fundació Institut d'Investigació Sanitària Illes Balears (IdISBa), Department of Cardiology, Carretera de Valldemossa, 79, 07120, Palma, Balearic Islands, Spain.
Department of Cardiology, Hospital Universitari Son Espases, Carretera de Valldemossa, 79, Palma, Illes Balears, Spain.

Miriam de Nadal (M)

Department of Anaesthesiology and Intensive Care, Hospital Universitari Vall d'Hebron, Passeig de la Vall d'Hebron, 119, 08035, Barcelona, Spain. miriam.denadal@vallhebron.cat.

Jordi Ordonez-Llanos (J)

Department of Biochemistry, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, 08026, Barcelona, Spain.
Foundation for Clinical Biochemistry & Molecular Pathology, Barcelona, Spain.

Mercedes Rivas-Lasarte (M)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, 08026, Barcelona, Spain.
Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, C. Joaquín Rodrigo, 1, 28222, Majadahonda, Madrid, Spain.

Abdel-Hakim Moustafa (AH)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, 08026, Barcelona, Spain.

Eduard Solé-González (E)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, 08026, Barcelona, Spain.
Department of Cardiology, Hospital Clinic i Provincial, C. de Villarroel, 170, 08036, Barcelona, Spain.

Pilar Paniagua-Iglesias (P)

Department of Anaesthesia and Pain Management, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, 08026, Barcelona, Spain.

Xavier Garcia-Moll (X)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, 08026, Barcelona, Spain.

David Viladés-Medel (D)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, 08026, Barcelona, Spain.

Rubén Leta-Petracca (R)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, 08026, Barcelona, Spain.

Gerard Oristrell (G)

Department of Cardiology, Hospital Universitari Vall d'Hebron, Passeig de la Vall d'Hebron, 119, 08035, Barcelona, Spain.

Javier Zamora (J)

Clinical Biostatistics Unit, IRYCIS, Hospital Universitario Ramon y Cajal, M-607, 9,100, 28034, Madrid, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Ignacio Ferreira-González (I)

Department of Cardiology, Hospital Universitari Vall d'Hebron, Passeig de la Vall d'Hebron, 119, 08035, Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Pablo Alonso-Coello (P)

IIB SANT PAU, Institut d'Investigació Biomèdica Sant Pau, Sant Quintí 77, 08041, Barcelona, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Francesc Carreras-Costa (F)

Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Sant Quintí 89, 08026, Barcelona, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH